Navigation Links
Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook

MELVILLE, N.Y., May 1 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's leading provider of comprehensive home health services, today reported the following financial results for the first quarter ended March 30, 2008:

-- Net revenues increased 8% to $323.7 million versus the first quarter

ended April 1, 2007.

-- Net income increased 13% to $7.7 million, or $0.27 per diluted share,

versus $6.8 million, or $0.24 per diluted share, for the prior year

period. Average diluted shares were 29.0 million versus 28.4 million in

the 2007 first quarter.

-- Earnings before interest, taxes, depreciation and amortization (EBITDA)

increased 3% to $23.8 million in the first quarter of 2008. EBITDA as a

percentage of net revenues was 7.4% in the 2008 first quarter versus

7.7% in the prior year period.

-- EBITDA included restructuring and integration costs of $0.3 million for

the first quarter of 2008 as compared to $1.0 million for the prior

year period.

"Gentiva's first quarter was an important transitional period as we adapted to new Medicare Prospective Payment System (PPS) rules, integrated our recent Mississippi acquisition and implemented contract renewals within CareCentrix," said Gentiva Chairman and CEO Ron Malone. "While we were pleased with our revenue growth, some of the quarter's events had a short-term, moderating effect on profitability. However, we are able to reaffirm our financial outlook for the full year, based on our review of cur 150,543

Medicaid and local government 35,365 38,327

Commercial insurance and other (4) 128,677 110,672

Total net revenues $323,722 $299,542

A reconciliation of EBITDA to Net income

- As Reported amounts follows: (2)

1st Quarter

2008 2007

EBITDA (3) $23,794 $23,139

Depreciation and amortization (5,151) (4,783)

Interest expense, net (5,426) (6,322)

Income before income taxes 13,217 12,034

Income tax expense (5) (5,494) (5,195)

Net income - As Reported $7,723 $6,839


(1) The Company's senior management evaluates performance and allocates

resources based on operating contributions of the reportable segments,

which exclude corporate expenses, depreciation, amortization, and

interest expense (net), but include revenues and all other costs

directly attributable to the specific segment.

(2) EBITDA, a non-GAAP financial measure, is defined as income before

interest expense (net of interest income), income taxes, depreciation

and amortization. Management uses EBITDA to evaluate overall

performance and compare current operating results with other companies

in the healthcare industry. EBITDA should not be considered in

isolation or as a substitute for net income, operating income or cash

flow statement data determined in accordance with accounting

principles generally accepted in the United States. Because EBITDA is

not a measure of financial performance under accounting principles

generally accepted in the United States and is susceptible to varying

calculations, it may not be comparable to similarly titled measures in

other companies.

(3) Operating contribution and EBITDA for the first quarter of 2008

included restructuring and integration costs of $0.3 million, of which

$0.1 million is associated with the Home Health segment, and

$0.2 million is included in corporate expenses. For the first quarter

of 2007, operating contribution and EBITDA included $0.3 million

associated with the Home Health segment and $0.7 million associated

with corporate expenses.

(4) Commercial insurance and other revenues included revenues from

Medicare Advantage business paid on an episodic basis of $11.1 million

for the first quarter of 2008 and $5.4 million for the first quarter

of 2007.

(5) The Company's effective tax rate was 41.6% and 43.2% for the first

quarters of 2008 and 2007, respectively.

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels, including changes to the Medicare home health Prospective Payment System effective January 1, 2008; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 30, 2007.

Financial and Investor Contact: John R. Potapchuk


Media Contact: David Fluhrer



rent business trends, our progress in adapting to the changed Medicare environment, and our commercial business opportunities. We expect 2008 to be another good year for Gentiva."

The Company noted the following first quarter performance highlights in its Home Health segment:

-- Home Health revenues were up 6% to $217.0 million versus the prior year

period, driven primarily by continuing growth from the Company's

expanding specialty programs, an increase in revenues from the

segment's commercial business as a result of the Company's ongoing

pricing strategy, and the inclusion of about $3 million in net revenues

from Home Health Care Affiliates, Inc., in Mississippi, which was

acquired by Gentiva on February 29, 2008.

-- Home Health operating contribution rose 4% to $31.2 million, with the

operating contribution margin at 14.4% in the first quarter of 2008

versus 14.6% in the prior year period. While the segment's operating

contribution has continued to benefit from the change in revenue mix to

higher-margin payers, results were affected by costs related primarily

to Gentiva's adoption of new PPS rules and recruitment initiatives to

grow capacity and productivity.

-- Revenues for Gentiva's Medicare PPS home health business increased more

than 7% versus the prior year period. Patient admissions remained

strong, although the current impact of new PPS rules contributed to a

revenue growth rate below those of recent quarters. Medicare Advantage

revenues in Home Health -- under which Gentiva is paid for patient

episodes similar to the rate structure and levels of Medicare PPS --

more than doubled during the first quarter versus the prior year

period. As a result, growth in episodic revenues (the combined

revenues from Medicare PPS and Medicare Advantage business paid on an

episodic basis) was 11% year-over-year, despite the adverse impact of

PPS changes.

Gentiva reported the following results in its CareCentrix and Other Related Services segments:

-- Revenues for CareCentrix rose more than 18% to $77.8 million as this

segment continued to benefit from its servicing of increased

managed care membership enrollments and new business.

-- CareCentrix' operating contribution declined by 9% to $6.3 million due

primarily to expected short-term increases in utilization under

capitated agreements, selected pricing changes resulting from a recent

contract extension with CIGNA HealthCare, and investments in

CareCentrix' expanded sales force. The Company anticipates additional

business opportunities for CareCentrix during the remainder of 2008,

including the continuing shift of CIGNA's membership from capitated to

fee-for-service plans, and potential benefits from CIGNA's

first quarter acquisition of Great-West Healthcare.

-- Net revenues and operating contribution for the smaller Other Related

Services segment, which consists of hospice, respiratory and home

medical equipment, infusion therapy and consulting, were slightly below

the prior year period as the Company continued to make investments and

operational changes aimed at improving the segment's financial


During the first quarter of 2008, Gentiva used $43 million of cash and incurred an additional $12 million in debt to fund the Home Health Care Affiliates acquisition. Despite the resulting increase in long-term debt to $322 million at March 30, 2008, Gentiva's leverage ratio remains below 3.0 and this has allowed the Company to maintain lower interest margins on its revolving credit and term loan borrowings as compared to the prior year.

Gentiva also reaffirmed its 2008 financial outlook of net revenues in a range of $1.28 billion to $1.32 billion and diluted earnings per share in a range between $1.32 and $1.40.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its first quarter results during its conference call and live web cast to be held Thursday, May 1, 2008, at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #42736083. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log onto to hear the web cast. This press release is accessible at and a transcript of the conference call is expected to be available on the site within 36 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site,, and its investor relations section at GTIV-E

(tables and notes follow)

(in 000's, except per share data) 1st Quarter

2008 2007

Statements of Income

Net revenues $323,722 $299,542

Cost of services and goods sold 187,199 170,121

Gross profit 136,523 129,421

Selling, general and administrative expenses 117,880 111,065

Operating income 18,643 18,356

Interest expense (6,093) (7,139)

Interest income 667 817

Income before income taxes 13,217 12,034

Income tax expense 5,494 5,195

Net income $7,723 $6,839

Earnings per Share

Net income:

Basic $0.27 $0.25

Diluted $0.27 $0.24

Average shares outstanding:

Basic 28,282 27,530

Diluted 29,043 28,439

Condensed Balance Sheets

ASSETS Mar 30, 2008 Dec 30, 2007

Cash, cash equivalents and

restricted cash (A) $16,382 $36,181

Short-term investments (B) 1,350 31,250

Accounts receivable, net (C) 230,190 207,801

Deferred tax assets 17,551 18,859

Prepaid expenses and other current assets 16,041 14,415

Total current assets 281,514 308,506

Long-term investments (B) 12,641 -

Fixed assets, net 62,534 59,562

Intangible assets, net 233,872 211,602

Goodwill 310,909 276,100

Other assets 25,893 26,463

Total assets $927,363 $882,233


Current portion of long-term debt $3,072 $2,304

Accounts payable 24,219 20,093

Payroll and related taxes 28,057 17,163

Deferred revenue 31,790 29,015

Medicare liabilities 8,257 7,985

Cost of claims incurred but not reported 22,732 24,321

Obligations under insurance programs 36,733 36,816

Other accrued expenses 39,616 42,282

Total current liabilities 194,476 179,979

Long-term debt 318,928 307,696

Deferred tax liabilities, net 55,218 48,572

Other liabilities 21,672 22,557

Shareholders' equity 337,069 323,429

Total liabilities and

shareholders' equity $927,363 $882,233

Common shares outstanding 28,402 28,046

(A) Cash, cash equivalents and restricted cash included restricted cash of

$0.3 million at March 30, 2008 and $22.0 million at December 30, 2007.

(B) Short-term and long-term investments at March 30, 2008 and

December 30, 2007 consisted of AAA-rated auction rate securities. At

March 30, 2008, long-term investments were presented net of a

$0.4 million valuation allowance, the charge for which was recorded in

Shareholders' Equity.

(C) Accounts receivable, net, included an allowance for doubtful accounts

of $9.3 million and $9.4 million at March 30, 2008 and

December 30, 2007, respectively.

(in 000's) 1st Quarter

Condensed Statements of Cash Flows 2008 2007


Net income $7,723 $6,839

Adjustments to reconcile net income to

net cash provided by operating activities:

Depreciation and amortization 5,151 4,783

Amortization of debt issuance costs 287 206

Provision for doubtful accounts 2,600 1,992

Equity-based compensation expense 1,734 1,652

Windfall tax benefits associated

with equity-based compensation (1,235) (241)

Deferred income taxes 4,848 3,699

Changes in assets and liabilities,

net of acquired business:

Accounts receivable (19,598) (17,741)

Prepaid expenses and other current assets (2,151) (4,863)

Current liabilities 8,825 18,660

Other, net (49) 695

Net cash provided by operating activities 8,135 15,681


Purchase of fixed assets (6,624) (6,445)

Acquisition of businesses, net of

cash acquired (47,405) -

Purchases of short-term investments

available-for-sale (28,000) (17,000)

Maturities of short-term investments

available-for-sale 44,900 12,800

Net cash used in investing

activities (37,129) (10,645)


Proceeds from issuance of common stock 4,119 2,188

Windfall tax benefits associated

with equity-based compensation 1,235 241

Borrowings under revolving credit facility 12,000 -

Home Health Care Affiliates debt repayments (7,420) -

Debt issuance costs (432) -

Other debt repayments - (7,000)

Repayment of capital lease obligations (307) (294)

Net cash provided by (used in)

financing activities 9,195 (4,865)

Net change in cash, cash equivalents

and restricted cash (19,799) 171

Cash, cash equivalents and restricted cash

at beginning of period 36,181 32,910

Cash, cash equivalents and

restricted cash at end of period $16,382 $33,081



Interest paid $5,702 $7,912

Income taxes paid, net of refunds $416 $286

(in 000's)

Supplemental Information 1st Quarter

2008 2007

Segment Information (1)

Net revenues

Home Health $217,000 $205,031

CareCentrix 77,848 65,890

Other Related Services 29,818 30,563

Intersegment revenues (944) (1,942)

Total net revenues $323,722 $299,542

Operating contribution (3)

Home Health $31,202 $29,988

CareCentrix 6,326 6,954

Other Related Services 2,845 3,987

Total operating contribution 40,373 40,929

Corporate expenses (16,579) (17,790)

Depreciation and amortization (5,151) (4,783)

Interest expense, net (5,426) (6,322)

Income before income taxes $13,217 $12,034

1st Quarter

2008 2007

Net Revenues by Major Payer Source:


Home Health $145,106 $135,254

Other 14,574 15,289

Total Medicare 159,680

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gentiva(R) Health Services Files Universal Shelf Registration Statement
2. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
3. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
4. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
5. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
6. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
7. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
8. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
9. Gentiva(R) Health Services to Present March 3rd at Raymond James 29th Annual Institutional Investors Conference in Orlando
10. Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi
11. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Khanna Vision Institute based in Los Angeles, announced ... November 25th 2015. Peer Certification by the Board is done so the public knows ... is first obtained after the completion of three years of training or Residency in ...
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion from Pixel ... specially for Final Cut Pro X. FCPX users can now apply ... controls. Destoying and creating chaotic distortion is now quick and simple, putting film ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... ... exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton to ... at the Radiological Society of North America (RSNA) 2015 Annual Meeting and continues ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. ... , With possible savings of up to 20% off orders $80 or more to free ... website every few hours. , As a competitive e-commerce website for skin care and cosmetic ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Nov. 29, 2015 CIVCO Medical Solutions ... at the Radiological Society of North ... Chicago November 29 – December 4, ... to offer customers unrivaled versatility, enhanced user experience ... --> ...
(Date:11/27/2015)... 27, 2015 Une nouvelle ... au Bremachlorin contre le cancer avancé.    ... combiner l,immunothérapie au traitement photodynamique au Bremachlorin contre ... Une nouvelle approche consistant à combiner l,immunothérapie ... avancé.    Clinical Cancer Research ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   Clinical ... --> Clinical Cancer Research vom ...
Breaking Medicine Technology: